David Shao is the founder of YS Biopharma. Latest round: Series B. Backed by Oceanpine Capital, OrbiMed Advisors, F-Prime.
David Shao served as the director, president, and chief executive officer of Yisheng Biopharma from February 2018 to December 2020. Before this, he was the chief financial officer and global business head of the same company since October 2010. He also held roles as senior vice president of finance and CFO at Aoxing Pharmaceutical Company, Inc.
Full founder directory · Investor directory · Company funding database · Fundraising library